Ohno A, Inagaki C, Honda K, Sugino N
Department of Medicine, Tokyo Women's Medical College, Japan.
Nihon Jinzo Gakkai Shi. 1992 Apr;34(4):405-10.
In order to compare the protective effects of angiotensin converting enzyme inhibitors (ACEI) and calcium channel blockers (CCB) on the renal function in experimental nephritis, nephrotoxic serum nephritis was induced in male spontaneously hypertensive rats (SHR). The above drugs were then chronically administered to different groups, as follows: the ACEI-treated group (n = 7) received captopril (150 mg/kg/day), and the CCB-treated group (n = 6) was given both nifedipine (40 mg/kg/day) and nisoldipine (20 mg/kg/day). The control group (n = 8) received a placebo. Although the control group developed marked hypertension and proteinuria, the rats treated with either ACEI or CCB demonstrated a significant and equivalent decrease in mean arterial pressure and urinary protein excretion. At 15 weeks after the injection of nephrotoxic serum, all rats were anesthetized with Inactin, and the glomerular filtration rate (GFR) and renal plasma flow (RPF) were measured. In the control group, GFR and RPF were markedly attenuated. However, both were preserved at much higher levels in the ACEI-treated group, and GFR was also maintained to a similar degree in the CCB-treated group. Histological studies were carried out after the clearance studies. As a result, it was found that the ACEI treatment significantly limited the development of glomerulosclerosis, whereas CCB modestly ameliorated the glomerular structural lesions. Moreover, ACEI significantly reduced the serum cholesterol, while CCB did not exert such an effect. These results suggest that both ACEI and CCB have a therapeutic effect in experimental glomerulonephritis models which are accompanied by hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)
为比较血管紧张素转换酶抑制剂(ACEI)和钙通道阻滞剂(CCB)对实验性肾炎肾功能的保护作用,在雄性自发性高血压大鼠(SHR)中诱发肾毒性血清性肾炎。然后将上述药物长期给予不同组,如下:ACEI治疗组(n = 7)接受卡托普利(150毫克/千克/天),CCB治疗组(n = 6)给予硝苯地平(40毫克/千克/天)和尼索地平(20毫克/千克/天)。对照组(n = 8)接受安慰剂。尽管对照组出现明显高血压和蛋白尿,但用ACEI或CCB治疗的大鼠平均动脉压和尿蛋白排泄均显著且同等程度降低。在注射肾毒性血清15周后,所有大鼠用安泰酮麻醉,测量肾小球滤过率(GFR)和肾血浆流量(RPF)。在对照组中,GFR和RPF明显降低。然而,在ACEI治疗组中两者均保持在更高水平,在CCB治疗组中GFR也维持在相似程度。在清除研究后进行组织学研究。结果发现,ACEI治疗显著限制了肾小球硬化的发展,而CCB适度改善了肾小球结构病变。此外,ACEI显著降低血清胆固醇,而CCB未产生这种作用。这些结果表明,ACEI和CCB在伴有高血压的实验性肾小球肾炎模型中均有治疗作用。(摘要截短至250字)